Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.

Raizada N, Sachdeva KS, Sreenivas A, Vadera B, Gupta RS, Parmar M, Kulsange S, Babre A, Thakur R, Gray C, Ramachandran R, Alavadi U, Ghedia M, Vollepore B, Dewan P, Boehme C, Paramsivan CN.

PLoS One. 2014 Feb 26;9(2):e89301. doi: 10.1371/journal.pone.0089301.

2.

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.

Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD.

Lancet. 2011 Apr 30;377(9776):1495-505. doi: 10.1016/S0140-6736(11)60438-8.

3.

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N.

Cochrane Database Syst Rev. 2014 Jan 21;(1):CD009593. doi: 10.1002/14651858.CD009593.pub3. Review.

4.

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.

Sachdeva KS, Raizada N, Sreenivas A, Van't Hoog AH, van den Hof S, Dewan PK, Thakur R, Gupta RS, Kulsange S, Vadera B, Babre A, Gray C, Parmar M, Ghedia M, Ramachandran R, Alavadi U, Arinaminpathy N, Denkinger C, Boehme C, Paramasivan CN.

PLoS One. 2015 May 21;10(5):e0126065. doi: 10.1371/journal.pone.0126065.

5.

Diagnosing pulmonary tuberculosis with the Xpert MTB/RIF test.

Bodmer T, Ströhle A.

J Vis Exp. 2012 Apr 9;(62):e3547. doi: 10.3791/3547.

6.

The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.

Pimkina E, Zablockis R, Nikolayevskyy V, Danila E, Davidaviciene E.

Respir Med. 2015 Nov;109(11):1484-9. doi: 10.1016/j.rmed.2015.07.006.

PMID:
26403251
7.

Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis.

Rufai SB, Kumar P, Singh A, Prajapati S, Balooni V, Singh S.

J Clin Microbiol. 2014 Jun;52(6):1846-52. doi: 10.1128/JCM.03005-13.

8.

Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population.

Raizada N, Sachdeva KS, Swaminathan S, Kulsange S, Khaparde SD, Nair SA, Khanna A, Chopra KK, Hanif M, Sethi GR, Umadevi KR, Keshav Chander G, Saha B, Shah A, Parmar M, Ghediya M, Jaju J, Boehme C, Paramasivan CN.

PLoS One. 2015 Oct 15;10(10):e0140375. doi: 10.1371/journal.pone.0140375.

9.

Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.

Raizada N, Sachdeva KS, Nair SA, Kulsange S, Gupta RS, Thakur R, Parmar M, Gray C, Ramachandran R, Vadera B, Ekka S, Dhawan S, Babre A, Ghedia M, Alavadi U, Dewan P, Khetrapal M, Khanna A, Boehme C, Paramsivan CN.

PLoS One. 2014 Aug 20;9(8):e105346. doi: 10.1371/journal.pone.0105346.

10.

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.

Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, Bekker LG, Wood R.

PLoS Med. 2011 Jul;8(7):e1001067. doi: 10.1371/journal.pmed.1001067.

11.

Cost-benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals.

Diel R, Nienhaus A, Hillemann D, Richter E.

Eur Respir J. 2016 Feb;47(2):575-87. doi: 10.1183/13993003.01333-2015.

PMID:
26647440
12.
13.

Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study.

van Kampen SC, Susanto NH, Simon S, Astiti SD, Chandra R, Burhan E, Farid MN, Chittenden K, Mustikawati DE, Alisjahbana B.

PLoS One. 2015 Jun 15;10(6):e0123536. doi: 10.1371/journal.pone.0123536.

14.

[Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].

Ciftçi IH, Aslan MH, Aşık G.

Mikrobiyol Bul. 2011 Jan;45(1):43-7. Turkish.

PMID:
21341158
15.

Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India.

Raizada N, Sachdeva KS, Sreenivas A, Kulsange S, Gupta RS, Thakur R, Dewan P, Boehme C, Paramsivan CN.

PLoS One. 2015 Feb 6;10(2):e0116721. doi: 10.1371/journal.pone.0116721.

16.

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009593. doi: 10.1002/14651858.CD009593.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(1):CD009593.

17.

Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries.

Ardizzoni E, Fajardo E, Saranchuk P, Casenghi M, Page AL, Varaine F, Kosack CS, Hepple P.

PLoS One. 2015 Dec 15;10(12):e0144656. doi: 10.1371/journal.pone.0144656.

18.

Diagnostic accuracy and turnaround time of the Xpert MTB/RIF assay in routine clinical practice.

Kwak N, Choi SM, Lee J, Park YS, Lee CH, Lee SM, Yoo CG, Kim YW, Han SK, Yim JJ.

PLoS One. 2013 Oct 29;8(10):e77456. doi: 10.1371/journal.pone.0077456.

19.

Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.

Rabna P, Ramos J, Ponce G, Sanca L, Mané M, Armada A, Machado D, Vieira F, Gomes VF, Martins E, Colombatti R, Riccardi F, Perdigão J, Sotero J, Portugal I, Couto I, Atouguia J, Rodrigues A, Viveiros M.

PLoS One. 2015 May 27;10(5):e0127536. doi: 10.1371/journal.pone.0127536.

20.

Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.

Rachow A, Zumla A, Heinrich N, Rojas-Ponce G, Mtafya B, Reither K, Ntinginya EN, O'Grady J, Huggett J, Dheda K, Boehme C, Perkins M, Saathoff E, Hoelscher M.

PLoS One. 2011;6(6):e20458. doi: 10.1371/journal.pone.0020458.

Items per page

Supplemental Content

Support Center